A multicenter retrospective study reports that a fusion model combining MRI habitat radiomics, Vision Transformer deep ...

Hazel B. Nichols, PhD, and Jama J. Brookes, MPH, discuss prediagnosis symptoms among endometrial cancer survivors, which may ...

A prospective 43-patient study found that diffusion tensor imaging parameters, especially fractional anisotropy, ...

Oct 26 (Reuters) - The US health regulator has accepted Merck's experimental targeted drug for a priority review based on ...

Jun. 11, 2026 -- Endometrial cancer is the most common gynecologic cancer in the United States and the fourth most common cancer affecting women. One of its most important warning signs – abnormal ...

An experimental drug from Merck & Co. helped women with advanced endometrial cancer live significantly longer than those ...

Oct 26 (Reuters) - Merck's experimental targeted drug helped women with advanced endometrial cancer live longer and kept ...

The endometrium, the inner lining of the uterus, is the layer of tissue that thickens every month in preparation for a possible pregnancy. But just as a baby can grow there, so can nasty cancer cells.

Bhavana Pothuri, MD, discusses phase 3 TroFuse-005 data from ESMO, where sac-TMT improved PFS and OS vs chemotherapy in endometrial cancer.

Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically ...

Bhavana Pothuri, MD, discusses TroFuse-005 at ESMO 2026, including TROP2 expression, treatment sequencing, and the future of ...